Cancer Progress and Priorities: Breast Cancer
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Breast cancer is the most commonly diagnosed invasive cancer among women both globally and within the United States and the number one cause of cancer-related deaths among women globally (1, 2). Less than 1%of diagnosed breast cancers occur inmen (2) and, therefore, male breast cancer is not included in this report. Breast cancer is an etiologically and clinically heterogeneous disease. Many risk factors, primarily hormone related, have been identified and these associations can vary by breast cancer subtype. Survival has increased over the past few decades, with the introduction of screening mammography and improved treatments. However, progress has not been seen equally among all ethnicities/races or with all breast cancer subtypes (e.g., triple negative).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21551 · Cited by 20,160 · cited 3×
“Breast cancer is the most commonly diagnosed invasive cancer among women both globally and within the United States and the number one cause of cancer-related deaths among women globally (1, 2).”
BackgroundInfluentialAlcohol consumption and site-specific cancer risk: a comprehensive dose–response meta-analysis
Bagnardi, V, Rota, M., Botteri, E., Tramacere, I., Islami, F., Fedirko, V, Scotti, L., Jenab, M., Turati, F., Pasquali, E., et al. (2015) · British Journal of Cancer · doi:10.1038/bjc.2014.579 · Cited by 1,342
Global cancer in women: burden and trends.
Torre, L. A., Islami, F., Siegel, R. L., Ward, E. M., & Jemal, A. (2017) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-0858 · Cited by 1,245
Exemestane for Breast-Cancer Prevention in Postmenopausal Women
Goss, P. E., Ingle, J. N., Alés-Martínez, J. E., Cheung, A. M., Chlebowski, R. T., Wactawski-Wende, J., McTiernan, A., Robbins, J., Johnson, K. C., Martin, L. W., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103507 · Cited by 970 · cited 1×
“Trials of tamoxifen and raloxifene have shown a 50% reduction in breast cancer risk, primarily due to a reduction of hormone receptor–positive breast cancers (317, 325–327) and trials of aromatase inhibitors have shown similar reductions (328, 329).”
ResultYang, X. R., Chang-Claude, J., Goode, E. L., Couch, F. J., Nevanlinna, H., Milne, R. L., Gaudet, M., Schmidt, M. K., Broeks, A., Cox, A., et al. (2011) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djq526 · Cited by 691
Self-citationAdherence to Mediterranean Diet and Risk of Cancer: An Updated Systematic Review and Meta-Analysis
Schwingshackl, L., Schwedhelm, C., Galbete, C., & Hoffmann, G. (2017) · Nutrients · doi:10.3390/nu9101063 · Cited by 632
Cuzick, J., Sestak, I., Forbes, J. F., Dowsett, M., Knox, J., Cawthorn, S., Saunders, C., Roche, N., Mansel, R. E., von Minckwitz, G., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62292-8 · Cited by 590
Toledo, E., Salas-Salvadó, J., Donat-Vargas, C., Buil-Cosiales, P., Estruch, R., Ros, E., Corella, D., Fitó, M., Hu, F. B., Arós, F., et al. (2015) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.4838 · Cited by 528 · cited 1×
“Apart from the Mediterranean dietary pattern, including olive oil, decreasing risk (189), studies are inconsistent or weakly associated, and there may be substantial confounding with other lifestyle risk factors.”
Background(2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70301-2 · Cited by 399
Diabetes and breast cancer risk: A meta-analysis
Boyle, P., Boniol, M., Koechlin, A., Robertson, C., Valentini, F., Coppens, K., Fairley, L.-L., Boniol, M., Zheng, T., Zhang, Y., et al. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.414 · Cited by 358
Metadata
- Authors
- Houghton, S. C., & Hankinson, S. E.
- Venue
- Cancer Epidemiology, Biomarkers & Prevention
- Published
- 2021-05-01
- Volume
- 30
- Issue
- 5
- Pages
- 822-844
- ISSN
- 1055-9965 (ISSN-L)
- 1538-7755
- OpenAlex
- W3159913442
- Cited by
- 163
- References
- 19
- FWCI
- 7.26
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cancer Progress and Priorities: Breast Cancer. https://app.cochat.ai/papers/10.1158/1055-9965.epi-20-1193
- The paper
- Houghton, S. C., & Hankinson, S. E. (2021). Cancer Progress and Priorities: Breast Cancer. Cancer Epidemiology, Biomarkers & Prevention. https://doi.org/10.1158/1055-9965.epi-20-1193
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.